Biotech and Digital Health

Engitix, a British biotech focused on the extracellular matrix (ECM) to develop transformative therapies for cancer and fibrosis, has announced the closing of a Series A extension of €21 million. The new capital comes from investors including Netherton Investments, a fund managed on behalf of Mike Platt, co-founder and managing director of BlueCrest Capital Management. This move marks a significant moment in the European biotech landscape, where large-scale ECM data usage and

In a rapidly evolving field like biotechnology, AI for microbiological science is emerging as a driver of innovation capable of accelerating diagnosis, sample analysis, and understanding microbiomes. Spore.Bio, a Paris-based startup, is leading this trend marking a turning point with multimillion-dollar funding from Google.org and with the opening of Spore.Labs, an in-house research division dedicated to AI-native projects for public health and microbiology. The initiative re